Literature DB >> 25636926

Non-tuberculous mycobacterial infections after solid organ transplantation: a survival analysis.

S A Longworth1, E A Blumberg1, T D Barton1, C Vinnard2.   

Abstract

The relationship of non-tuberculous mycobacterial (NTM) infections and survival among solid organ transplant recipients is unknown. We conducted a retrospective cohort study to measure the impact of NTM infection on survival in this patient population, comparing the effect of Mycobacterium abscessus infection with that of infections due to other pathogenic NTM species. We identified 33 patients with NTM infection post-transplantation, 18 with infection that was diagnosed within the first year. Although drug resistance was common among M. abscessus isolates, patients with M. abscessus infection did not have increased mortality compared with patients with other types of NTM infections (p 0.64). In contrast, we observed a significant association overall between early NTM infection and 3-year mortality post-transplantation (hazard ratio 8.76, 95% CI 2.69-28.57). The mortality burden of NTM infection following transplantation may be due to factors other than the virulence of the organisms. Multicentre studies are needed to identify the optimal approach for diagnosing and treating these uncommon but serious infections.
Copyright © 2014 Shenyang Pharmaceutical University. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Drug resistance; Mycobacterium abscessus; epidemiology; non-tuberculous mycobacteria; transplantation

Mesh:

Substances:

Year:  2014        PMID: 25636926      PMCID: PMC4313615          DOI: 10.1016/j.cmi.2014.07.001

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  14 in total

1.  Factors associated with mortality in transplant patients with invasive aspergillosis.

Authors:  John W Baddley; David R Andes; Kieren A Marr; Dimitrios P Kontoyiannis; Barbara D Alexander; Carol A Kauffman; Robert A Oster; Elias J Anaissie; Thomas J Walsh; Mindy G Schuster; John R Wingard; Thomas F Patterson; James I Ito; O Dale Williams; Tom Chiller; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2010-06-15       Impact factor: 9.079

2.  Infections due to rapidly growing mycobacteria.

Authors:  Mary A De Groote; Gwen Huitt
Journal:  Clin Infect Dis       Date:  2006-05-11       Impact factor: 9.079

Review 3.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

4.  Klebsiella pneumoniae infection in solid organ transplant recipients: epidemiology and antibiotic resistance.

Authors:  L Linares; C Cervera; I Hoyo; G Sanclemente; F Marco; F Cofán; M J Ricart; M Navasa; A Moreno
Journal:  Transplant Proc       Date:  2010-10       Impact factor: 1.066

5.  Use of the MGB Eclipse system and SmartCycler PCR for differentiation of Mycobacterium chelonae and M. abscessus.

Authors:  Joann L Cloud; Karen Hoggan; Evgeniy Belousov; Samuel Cohen; Barbara A Brown-Elliott; Linda Mann; Rebecca Wilson; Wade Aldous; Richard J Wallace; Gail L Woods
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality.

Authors:  Hsuanwen C Huang; S Samuel Weigt; Ariss Derhovanessian; Vyacheslav Palchevskiy; Abbas Ardehali; Rajan Saggar; Rajeev Saggar; Bernard Kubak; Aric Gregson; David J Ross; Joseph P Lynch; Robert Elashoff; John A Belperio
Journal:  J Heart Lung Transplant       Date:  2011-04-08       Impact factor: 10.247

7.  The impact of confounder selection criteria on effect estimation.

Authors:  R M Mickey; S Greenland
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

8.  Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation.

Authors:  W Chalermskulrat; N Sood; I P Neuringer; T M Hecker; L Chang; M P Rivera; L J Paradowski; R M Aris
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

9.  The ESX-5 secretion system of Mycobacterium marinum modulates the macrophage response.

Authors:  Abdallah M Abdallah; Nigel D L Savage; Maaike van Zon; Louis Wilson; Christina M J E Vandenbroucke-Grauls; Nicole N van der Wel; Tom H M Ottenhoff; Wilbert Bitter
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  Late-onset posttraumatic skin and soft-tissue infections caused by rapid-growing mycobacteria in tsunami survivors.

Authors:  Pia Appelgren; Filip Farnebo; Leif Dotevall; Marie Studahl; Bodil Jönsson; Bjorn Petrini
Journal:  Clin Infect Dis       Date:  2008-07-15       Impact factor: 9.079

View more
  8 in total

1.  Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection.

Authors:  Don Hayes; Rajni Kant Shukla; Yizi Cheng; Emrah Gecili; Marlena R Merling; Rhonda D Szczesniak; Assem G Ziady; Jason C Woods; Luanne Hall-Stoodley; Namal Pm Liyanage; Richard T Robinson
Journal:  JCI Insight       Date:  2022-06-22

2.  Mycobacterium abscessus Infections in Solid Organ Transplant Recipients: Single-Center Experience in the United States, 2013-2018.

Authors:  Yosuke Ebisu; Yoichiro Natori; Gemma Rosello; Shweta Anjan; Jacques Simkins; Jose F Camargo; Michele I Morris; Octavio V Martinez; Lilian M Abbo
Journal:  Open Forum Infect Dis       Date:  2022-05-18       Impact factor: 4.423

3.  Pneumonia due to Mycobacterium cosmeticum in a renal transplant recipient.

Authors:  Ahmed Aljishi; Marwan Jabr Alwazzeh; Mar Kristjansson
Journal:  BMJ Case Rep       Date:  2021-03-02

4.  Mycobacterium abscessus disease in lung transplant recipients: Diagnosis and management.

Authors:  Satish Chandrashekaran; Patricio Escalante; Cassie C Kennedy
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2017-12

5.  rpoB Targeted Loop-Mediated Isothermal Amplification (LAMP) Assay for Consensus Detection of Mycobacteria Associated With Pulmonary Infections.

Authors:  Simon Grandjean Lapierre; Michel Drancourt
Journal:  Front Med (Lausanne)       Date:  2018-11-28

Review 6.  Functional Analysis of Anti-cytokine Autoantibodies Using Flow Cytometry.

Authors:  Patricia A Merkel; Terri Lebo; Vijaya Knight
Journal:  Front Immunol       Date:  2019-07-12       Impact factor: 7.561

7.  Long-term case-fatality rate of nontuberculous mycobacterial disease in people living with HIV.

Authors:  Jingjing Hu; Ling Gu; Yueming Shao; Renfang Zhang; Tangkai Qi; Jianjun Sun; Zhenyan Wang; Wei Song; Yang Tang; Jiangrong Wang; Shuibao Xu; Junyang Yang; Yinzhong Shen; Li Liu; Jun Chen; Hongzhou Lu
Journal:  Infect Dis Poverty       Date:  2022-02-07       Impact factor: 4.520

8.  Diagnosis of mycobacterial infections based on acid-fast bacilli test and bacterial growth time and implications on treatment and disease outcome.

Authors:  Fabiane N Riello; Rebecca T S Brígido; Sergio Araújo; Tomaz A Moreira; Luiz Ricardo Goulart; Isabela M B Goulart
Journal:  BMC Infect Dis       Date:  2016-04-01       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.